What We're Reading: Page 264
Industry reads hand-picked by our editors
May 22, 2018
-
The New York Times
New cancer treatments lie hidden under mountains of paperwork
-
San Francisco Business Times
'Bursting at the seams,' this high-profile Peninsula biotech company is moving to a bigger home
-
Bloomberg
Deadly Chinese Fentanyl Is Creating a New Era of Drug Kingpins
May 21, 2018
May 18, 2018
May 17, 2018
-
NPR
How a drugmaker gamed the system to keep generic competition away
-
Mother Jones
A promising new Ebola vaccine is about to be put to the test
-
Vox
100 million Americans have chronic pain. Very few use one of the best tools to treat it.
-
HealthNewsReview.org
ASCO 2018: How a major medical meeting uses embargoes to shape the news, and what the consequences may be
May 16, 2018
May 15, 2018
-
U.S. News & World Report
Will Alzheimer's research and treatment follow the AIDS model? Or malaria's?
-
Xconomy
Arch’s Bob Nelsen on big biotech and why pharma should be very afraid
-
The New York Times
My adventures with the trip doctors
May 14, 2018
-
The Washington Post
Viagra and many other drugs were discovered by chance. Now science is hoping to change that.
-
Nature
Blood, sweat and tears in biotech — the Theranos story
-
Financial Times
Pharma investors mobilise on reputational risk concerns
-
The Boston Globe
This Cambridge nonprofit is seeking every drug ever developed
Previous
